ATYR PHARMA INC (ATYR)
US0021202025 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.81M | -50.40M | -45.34M | -33.78M | -16.23M | |||
| Depreciation Amortization | 708.00K | 592.00K | 232.00K | 475.00K | 569.00K | |||
| Change In Working Capital | -5.02M | 15.01M | -833.00K | -2.59M | -2.26M | |||
| Interest Paid | 146.00K | 172.00K | 54.00K | 0.00 | 308.00K | |||
| Other non cash items | 1.08M | 1.57M | 4.06M | 2.81M | 2.62M | |||
| OPERATING CASH FLOW | -67.05M | -33.22M | -41.89M | -33.08M | -15.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -57.00K | -4.21M | -1.64M | -192.00K | -202.00K | |||
| Other Investing Activity | 41.19M | -15.91M | 48.89M | -91.37M | 7.10M | |||
| INVESTING CASH FLOW | 41.14M | -20.13M | 47.24M | -91.57M | 6.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -484.00K | -394.00K | -66.00K | 0.00 | -9.08M | |||
| Stock Issued/Repurchased | 27.54M | 66.62M | 5.52M | 110.03M | 25.23M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 27.06M | 66.23M | 5.45M | 110.03M | 16.14M | |||
| CHANGE IN CASH | 1.15M | 12.88M | 10.81M | -14.62M | 7.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -67.05M | -33.22M | -41.89M | -33.08M | -15.30M | |||
| Capital Expenditure | -57.00K | -4.21M | -1.64M | -192.00K | -202.00K | |||
| FREE CASH FLOW | -67.11M | -37.44M | -43.53M | -33.27M | -15.50M | |||
All data in USD